Although we did not test many other combinations, the likelihood is that whether a substrate is primary or secondary is irrelevant for stimulation of NLRP3 inflammasome activation, suggesting that NLRP3 and IL‐1 secretion will have an impact in most neuronopathic lysosomal diseases. The gene discussed is IL1A; the disease is Lysosomal disease.